Chemed Corp (CHE) Social Stream
Chemed Corp (CHE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering CHE.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 26 weeks, CHE's average price target has gone up $20.33.
Over the past 19 months, CHE's average upside potential has been 20.75%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CHE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
CHE's average broker recommendation rating improved by 0 over the prior 31 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- CHE has a greater average analyst price target than nearly 100% of Healthcare stocks.
- Chemed Corp's variance in analysts' estimates is lower than 93.55% of stocks in the mid market cap category.
- The number of analysts covering the stock of CHE is greater than 9.26% of stocks in the mid market cap category.
- The upside potential (average analyst target price relative to current price) of CHE is greater than 11.01% of Healthcare stocks.
Is CHE a Buy, Hold or Sell? See the POWR Ratings now!